The objective of this study is to demonstrate high-resolution positronium lifetime tomography using a 3-dimensional phantom with multiple radioisotopes at activity levels relevant to human imaging.

Endometrial cancer is the most common gynecologic malignancy worldwide, and its incidence and mortality rates have increased over the past decade. Although early-stage disease is effectively treated ...

Deep learning (DL) represents a promising technique for image restoration. We explored its ability to restore ultra-low-count [18F]FDG PET studies of the brain in subjects with dementia and in healthy ...

Dr. Christian (Chris) Behrenbruch is the founder and chief executive officer of Telix Pharmaceuticals Ltd. (ASX.TLX, NASDAQ.TLX). He has over 25 y of commercial experience in nuclear medicine and ...

The improved sensitivity of total-body (TB) PET/CT offers the possibility of reducing injected activities. The aim of our study was to define a lower limit of reduced injected activities in [18F]FDG ...

18F-flurpiridaz is a novel PET myocardial perfusion radiotracer with a high myocardial extraction fraction and low positron range, providing high-resolution images. Additionally, the linear ...

TO THE EDITOR: I thank Tran-Gia et al. and fully support their direction regarding the clinical implementation of dosimetry in radiopharmaceutical therapy ([1][1]). In a parallel development, it would ...

Diagnostic Performance of 18 F-Fluoroestradiol PET/CT for Axillary Lymph Node Metastasis in Invasive Lobular Carcinoma: A Prospective Feasibility Study ...

Introduction: The FDA recently approved 177 Lu PSMA 617 therapy for metastatic castration-resistant prostate cancer (mCRPC) patients.Per the VISION trial, this therapy prolongs overall survival by ...

Quantitative Analysis in Nuclear Medicine Imaging is an in-depth review of single-photon and PET nuclear medicine image reconstruction, correction, modeling, and analysis techniques, with a particular ...

329 Objectives Stimulant medications (methylphenidate and amphetamine) are the treatments of choice in ADHD and are believed to acutely compensate for a chronic dopamine (DA) deficit in this disorder.

The relationship between lesion absorbed dose (AD) and response in patients with metastatic castration-resistant prostate cancer undergoing [177Lu]Lu-PSMA-617 radiopharmaceutical therapy (RPT) remains ...